Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

6.1%

2 terminated out of 33 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

30%

3 of 10 completed with results

Key Signals

3 with results83% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (11)
Early P 1 (1)
P 1 (4)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed10
Recruiting9
Unknown5
Not Yet Recruiting4
Terminated2
Withdrawn2

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT04427384Recruiting

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

NCT06057168Phase 3CompletedPrimary

Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

NCT07085494Not ApplicableEnrolling By InvitationPrimary

Neurofeedback and Cognitive Training for PBTS

NCT03262636Phase 1CompletedPrimary

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

NCT06322342Phase 2Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT07264023Not Yet Recruiting

Correlation Between Nutritional Status of Childhood Neurological Tumors and Quality of Life

NCT05480644RecruitingPrimary

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

NCT07226466Not Yet Recruiting

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

NCT07179328Phase 1Recruiting

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

NCT06185686RecruitingPrimary

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

NCT07036783Not Yet Recruiting

3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study

NCT05831631RecruitingPrimary

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

NCT05775458RecruitingPrimary

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

NCT06929819Not ApplicableNot Yet Recruiting

Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor

NCT03213002Phase 1Recruiting

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

NCT06282562Not ApplicableRecruitingPrimary

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients

NCT05254197RecruitingPrimary

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

NCT04901806Phase 1Terminated

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

NCT03970499Not ApplicableCompletedPrimary

Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors

NCT06106997Not ApplicableUnknownPrimary

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Scroll to load more

Research Network

Activity Timeline